Showing results (641-650 of 2,410) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|April 18, 2024
Clinical and economic outcomes of assigning percutaneous coronary intervention patients to contrast-sparing strategies based on the predicted risk of contrast-induced acute kidney injuryRobert I Griffiths, Aparna Bhave, Alysha M McGovern, et al.Journal of Medical Economics|October 29, 2013
Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in previously untreated chronic hepatitis C genotype 1 patientsSandrine Cure, Florence Bianic, Sandra Gavart, et al.Journal of Medical Economics|December 20, 2013
An incidence model of the cost of advanced prostate cancer in SpainW M Hart, J Nazir, E Baskin-BeyJournal of Medical Economics|December 20, 2013
Cost minimization analysis of beta-blocker at the time of CT imaging for suspected of coronary heart disease in JapanAtaru Igarashi, Kaori Fujito, Masaharu Hirano, et al.Journal of Medical Economics|December 24, 2013
Frequency of blood glucose testing among insulin-treated diabetes mellitus patients in the United KingdomWon Chan Lee, Elise Smith, Barrie Chubb, et al.Journal of Medical Economics|August 29, 2014
Retrospective database study to assess the economic impact of hip fracture in the United KingdomDimitra Lambrelli, Russel Burge, Mireia Raluy-Callado, et al.Journal of Medical Economics|August 30, 2014
Budget impact analysis of a novel gene expression assay for the diagnosis of malignant melanomaDavid S Cassarino, Nicolas Lewine, Doria Cole, et al.Journal of Medical Economics|March 10, 2016
Hospital resource use of patients receiving isavuconazole vs voriconazole for invasive mold infections in the phase III SECURE trialDavid Horn, Debra Goff, Nikhil Khandelwal, et al.Journal of Medical Economics|June 29, 2016
A novel cost-effectiveness model of prescription eicosapentaenoic acid extrapolated to secondary prevention of cardiovascular diseases in the United StatesSephy Philip, Sumita Chowdhury, John R Nelson, et al.Journal of Medical Economics|June 2, 2016
The economic burden of end-of-life care in metastatic breast cancerThomas Bramley, Vincent Antao, Orsolya Lunacsek, et al.Pageof 241